ARCHIVES

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

Cancer Control RFA Announcements

March 9, 1979

NCI forms pediatric central IRB.

July 30, 2004

Fogarty Leads Grant Program On World Tobacco Research.

July 6, 2001

New Concepts Being Developed By Organ Systems Groups Described

January 2, 1987

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011